In chronic autoimmune diseases, such as systemic lupus erythematosus (SLE) and primary Sjögren's syndrome (pSS), a variety of B cell disturbances have been described, among them, increased CD11c+ B cells (1–3). Here, ITGAX is linked to systemic lupus erythematosus.